Joensuu H, Hohenberger P, Corless CL (2013) Gastrointestinal stromal tumour. Lancet 382(9896):973–983. https://doi.org/10.1016/S0140-6736(13)60106-3
Article CAS PubMed Google Scholar
Parab TM, DeRogatis MJ, Boaz AM et al (2019) Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol 10:144–154. https://doi.org/10.21037/jgo.2018.08.20
Article PubMed PubMed Central Google Scholar
Anderson WJ, Doyle LA (2021) Updates from the 2020 World Health Organization classification of soft tissue and bone tumours. Histopathology 78(5):644–657. https://doi.org/10.1111/his.14265
Mantese G (2019) Gastrointestinal stromal tumor: epidemiology, diagnosis, and treatment. Curr Opin Gastroenterol 35(6):555–559. https://doi.org/10.1097/MOG.0000000000000584
Article CAS PubMed Google Scholar
Akahoshi K, Oya M, Koga T, Shiratsuchi Y (2018) Current clinical management of gastrointestinal stromal tumor. World J Gastroenterol 24(26):2806–2817. https://doi.org/10.3748/wjg.v24.i26.2806
Article PubMed PubMed Central Google Scholar
Minoda Y, Esaki M, Ihara E et al (2022) Auxiliary diagnosis of subepithelial lesions by impedance measurement during endoscopic ultrasound guided fine-needle biopsy. Gastrointest Endosc S0016–5107(22):02197–02206. https://doi.org/10.1016/j.gie.2022.11.022
Zhang Y, Renberg S, Papakonstantinou A et al (2022) Diagnosing gastrointestinal stromal tumors: the utility of fine-needle aspiration cytology versus biopsy. Cancer Med 14:2729–2734. https://doi.org/10.1002/cam4.4630
Christensen AW, Goldberg AF (2022) Mitotic count of fine needle aspiration material of gastrointestinal stromal tumours of the stomach underestimates actual mitotic count. Cytopathology 331:100–106. https://doi.org/10.1111/cyt.13050
Fernández J, Gómez-Ruiz AJ, Olivares V et al (2018) Clinical and pathological features of “small” GIST (≤2 cm): What is their prognostic value? Eur J Surg Oncol 44:580–586. https://doi.org/10.1016/j.ejso.2018.01.087
Hølmebakk T, Wiedswang AM, Meza-Zepeda LA et al (2021) Integrating anatomical, molecular and clinical risk factors in gastrointestinal stromal tumor of the stomach. Ann Surg Oncol 28(11):6837–6845. https://doi.org/10.1245/s10434-021-09605-8
Article PubMed PubMed Central Google Scholar
Nishida T, Hølmebakk T, Raut CP, Rutkowski P (2019) Defining tumor rupture in gastrointestinal stromal tumor. Ann Surg Oncol 26(6):1669–1675. https://doi.org/10.1245/s10434-019-07297-9
Article PubMed PubMed Central Google Scholar
Hølmebakk T, Hompland I, Bjerkehagen B et al (2018) Recurrence-free survival after resection of gastric gastrointestinal stromal tumors classified according to a strict definition of tumor rupture: a population-based study. Ann Surg Oncol 25(5):1133–1139. https://doi.org/10.1245/s10434-018-6353-5
Casali PG, Blay JY, Abecassis N et al (2022) Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 33(1):20–33. https://doi.org/10.1016/j.annonc.2021.09.005
Article CAS PubMed Google Scholar
van der Graaf WTA, Tielen R, Bonenkamp JJ et al (2018) Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era. Br J Surg 105(8):1020–1027. https://doi.org/10.1002/bjs.10809
Article CAS PubMed PubMed Central Google Scholar
Randall RL, Benjamin RS, Boles S et al (2018) Soft Tissue Sarcoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16(5):536–563
Fairweather M, Balachandran VP, Li GZ et al (2018) Cytoreductive surgery for metastatic gastrointestinal stromal tumors treated with tyrosine kinase inhibitors: a 2-institutional analysis. Ann Surg 268(2):296–302. https://doi.org/10.1097/SLA.0000000000002281
Li J, Ye Y, Wang J et al (2017) Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor. Chin J Cancer Res 29(4):281–293. https://doi.org/10.21147/j.issn.1000-9604.2017.04.01
Article PubMed PubMed Central Google Scholar
Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39(10):1411–1419. https://doi.org/10.1016/j.humpath.2008.06.025
Li GZ, Raut CP (2019) Targeted therapy and personalized medicine in gastrointestinal stromal tumors: drug resistance, mechanisms, and treatment strategies. Onco Targets Ther 12:5123–5133. https://doi.org/10.2147/OTT.S180763
Article CAS PubMed PubMed Central Google Scholar
Yang J, Qingyao Wu, Lei Xu et al (2020) Integrating tumor and nodal radiomics to predict lymph node metastasis in gastric cancer. Radiother Oncol 150:89–96. https://doi.org/10.1016/j.radonc.2020.06.004
Wang Y, Liu W, Yang Yu et al (2020) CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer. Eur Radiol 30(2):976–986. https://doi.org/10.1007/s00330-019-06398-z
Li M, Zhang J, Dan Y et al (2020) A clinical-radiomics nomogram for the preoperative prediction of lymph node metastasis in colorectal cancer. J Transl Med 18(1):46. https://doi.org/10.1186/s12967-020-02215-0
Article CAS PubMed PubMed Central Google Scholar
Park S, Sham JG, Kawamoto S et al (2021) CT radiomics-based preoperative survival prediction in patients with pancreatic ductal adenocarcinoma. AJR Am J Roentgenol 217(5):1104–1112. https://doi.org/10.2214/AJR.20.23490
Jiang Y, Chen C, Xie J et al (2018) Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. EBioMedicine 36:171–182. https://doi.org/10.1016/j.ebiom.2018.09.007
Article PubMed PubMed Central Google Scholar
Autorino R, Gui B, Panza G et al (2022) Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy. Radiol Med 127(5):498–506. https://doi.org/10.1007/s11547-022-01482-9
Article PubMed PubMed Central Google Scholar
Dongsheng Gu, Yabin Hu, Ding H et al (2019) CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study. Eur Radiol 29(12):6880–6890. https://doi.org/10.1007/s00330-019-06176-x
Sun R, Limkin EJ, Vakalopoulou M et al (2018) A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol 19(9):1180–1191. https://doi.org/10.1016/S1470-2045(18)30413-3
Article CAS PubMed Google Scholar
Zhou C, Duan X, Zhang X et al (2016) Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour. Eur Radiol 26(9):3086–3093. https://doi.org/10.1007/s00330-015-4172-7
Zhang L, Kang L, Li G et al (2020) Computed tomography-based radiomics model for discriminating the risk stratification of gastrointestinal stromal tumors. Radiol Med 125(5):465–473. https://doi.org/10.1007/s11547-020-01138-6
Xue C, Yuan J, Lo GG et al (2021) Radiomics feature reliability assessed by intraclass correlation coefficient: a systematic review. Quant Imaging Med Surg 11(10):4431–4460. https://doi.org/10.21037/qims-21-86
Article PubMed PubMed Central Google Scholar
Zwanenburg A, Vallières M, Abdalah MA et al (2020) The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology 295(2):328–338. https://doi.org/10.1148/radiol.2020191145
van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 77(21):e104–e107. https://doi.org/10.1158/0008-5472
Article PubMed PubMed Central Google Scholar
Hepp T, Schmid M, Gefeller O, Waldmann E, Mayr A (2016) Approaches to regularized regression—a comparison between Gradient Boosting and the Lasso. Methods Inf Med 55(5):422–430. https://doi.org/10.3414/ME16-01-0033
Nattino G, Pennell ML, Lemeshow S (2020) Assessing the goodness of fit of logistic regression models in large samples: a modification of the Hosmer–Lemeshow test. Biometrics 76(2):549–560. https://doi.org/10.1111/biom.13249
Vassos N, Jakob J, Kähler G et al (2021) Preservation of organ function in locally advanced non-metastatic gastrointestinal stromal tumors (GIST) of the stomach by neoadjuvant imatinib therapy. Cancers (Basel) 13(4):586. https://doi.org/10.3390/cancers13040586
Article CAS PubMed Google Scholar
Marqueen KE, Moshier E, Bucksteinr M et al (2021) Neoadjuvant therapy for gastrointestinal stromal tumors: a propensity score-weighted analysis. Int J Cancer 149(1):177–185. https://doi.org/10.1002/ijc.33536
Article CAS PubMed Google Scholar
Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14(12):749–762. https://doi.org/10.1038/nrclinonc.2017.141
留言 (0)